Uterine sarcoma

C. F. Levenback; G. Tortolero-Luna; D. K. Pandey; A. Malpica; V. V. Baker; L. Whittaker; E. Johnson; M. F. Mitchell

Uterine sarcoma

C. F. Levenback, G. Tortolero-Luna, D. K. Pandey, A. Malpica, V. V. Baker, L. Whittaker, E. Johnson, M. F. Mitchell

Research output: Contribution to journal › Review article › peer-review

Abstract

Sarcomas are rare tumors with unpredictable prognosis. They are treated similarly to endometrial cancers. Little is known of epidemiologic risk factors for sarcoma; similarly, little work has been performed assessing molecular alterations in sarcomas. Because of their rarity, uterine sarcomas are not suitable for screening. Chemoprevention studies might target those at risk for recurrence or a second neoplasm.

Original language	English (US)
Pages (from-to)	457-473
Number of pages	17
Journal	Obstetrics and Gynecology Clinics of North America
Volume	23
Issue number	2
State	Published - 1996

ASJC Scopus subject areas

Obstetrics and Gynecology

Cite this

@article{5c7172b14d9141e695250b7d9014f00c,

title = "Uterine sarcoma",

abstract = "Sarcomas are rare tumors with unpredictable prognosis. They are treated similarly to endometrial cancers. Little is known of epidemiologic risk factors for sarcoma; similarly, little work has been performed assessing molecular alterations in sarcomas. Because of their rarity, uterine sarcomas are not suitable for screening. Chemoprevention studies might target those at risk for recurrence or a second neoplasm.",

author = "Levenback, {C. F.} and G. Tortolero-Luna and Pandey, {D. K.} and A. Malpica and Baker, {V. V.} and L. Whittaker and E. Johnson and Mitchell, {M. F.}",

year = "1996",

language = "English (US)",

volume = "23",

pages = "457--473",

journal = "Obstetrics and Gynecology Clinics of North America",

issn = "0889-8545",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Uterine sarcoma

AU - Levenback, C. F.

AU - Tortolero-Luna, G.

AU - Pandey, D. K.

AU - Malpica, A.

AU - Baker, V. V.

AU - Whittaker, L.

AU - Johnson, E.

AU - Mitchell, M. F.

PY - 1996

Y1 - 1996

N2 - Sarcomas are rare tumors with unpredictable prognosis. They are treated similarly to endometrial cancers. Little is known of epidemiologic risk factors for sarcoma; similarly, little work has been performed assessing molecular alterations in sarcomas. Because of their rarity, uterine sarcomas are not suitable for screening. Chemoprevention studies might target those at risk for recurrence or a second neoplasm.

AB - Sarcomas are rare tumors with unpredictable prognosis. They are treated similarly to endometrial cancers. Little is known of epidemiologic risk factors for sarcoma; similarly, little work has been performed assessing molecular alterations in sarcomas. Because of their rarity, uterine sarcomas are not suitable for screening. Chemoprevention studies might target those at risk for recurrence or a second neoplasm.

UR - http://www.scopus.com/inward/record.url?scp=0029938147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029938147&partnerID=8YFLogxK

M3 - Review article

C2 - 8784887

AN - SCOPUS:0029938147

SN - 0889-8545

VL - 23

SP - 457

EP - 473

JO - Obstetrics and Gynecology Clinics of North America

JF - Obstetrics and Gynecology Clinics of North America

IS - 2

ER -

Uterine sarcoma

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this